Hacettepe University Faculty of Medicine, Department of Ophthalmology, Ankara, Turkey
Hacettepe University Faculty of Medicine, Department of Pediatrics, Department of Pediatric Genetics, Ankara, Turkey
Turk J Ophthalmol. 2021 Apr 29;51(2):107-113. doi: 10.4274/tjo.galenos.2020.08377.
Congenital cataract is a challenging ophthalmological disorder which can cause severe visual loss. It can be diagnosed at birth or during the first year of life. Early diagnosis and treatment are crucial for the visual prognosis. It can be associated with various ocular and systemic abnormalities. Determining whether congenital cataract is isolated or associated with other pathology is an indispensable step for the prediction of potential vision as well as early diagnosis and treatment of conditions that can cause morbidity or mortality. Many genes have been identified in the molecular etiology of congenital cataract. Most mutations have been reported in the crystallin genes. Determination of the genetic cause may not only enable individualized genetic counseling but also help to identify concomitant ocular and/or systemic disorders depending on the characteristics of the genetic test used. Recently, next-generation sequencing in particular has become an evolving technology for determining the molecular etiology of congenital cataract and furthering our knowledge of the disease.
先天性白内障是一种具有挑战性的眼科疾病,可导致严重的视力丧失。它可以在出生时或生命的第一年被诊断出来。早期诊断和治疗对视觉预后至关重要。它可能与各种眼部和全身异常有关。确定先天性白内障是孤立的还是与其他病理学相关,对于预测潜在视力以及早期诊断和治疗可能导致发病率或死亡率的疾病是不可或缺的一步。许多基因已在先天性白内障的分子病因学中被确定。大多数突变已在晶体蛋白基因中报告。确定遗传原因不仅可以进行个体化的遗传咨询,还可以根据遗传测试的特点帮助识别伴随的眼部和/或全身性疾病。最近,下一代测序特别是确定先天性白内障分子病因学的一项不断发展的技术,使我们对该疾病有了更深入的了解。